Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04CSZ
|
||||
Former ID |
DAP000876
|
||||
Drug Name |
Menthol
|
||||
Synonyms |
Hexahydrothymol; Levomenthol; Levomentholum; Menthacamphor; Menthomenthol; Neoisomenthol; Racementhol; Racementholum; Racementol; Headache crystals; Menthol natural; Menthol racemic; Menthol racemique; Menthol racemique [French]; Menthol solution; Menthyl alcohol; Peppermint camphor; Racemic menthol; Robitussin Cough Drops; M0321; M0545; D-Menthol; D-Neomenthol; Dl-Menthol; Fisherman's friend lozenges; L-Menthol; Levomenthol [INN:BAN]; Levomentholum [INN-Latin]; Menthol (USP); Menthol (VAN); Menthol natural, brazilian; NOOLISFMXDJSKH-KXUCPTDWBX; Rac-Menthol; Racementhol [INN:BAN]; Racementholum [INN-Latin]; Racementol [INN-Spanish]; Tra-kill tracheal mite killer; D,l-Menthol; Dl-Menthol (JP15); Fisherman's friendlozenges (TN); L-Menthol (JP15); L-Menthol (TN); L-Menthol (natural); Dl-3-p-Menthanol; P-Menthan-3-ol; RACEMIC MENTHOL U.S.P.; U.S.P. Menthol; D-(-)-Menthol; D-p-Menthan-3-ol; L-(-)-Menthol; Menthol, (1alpha,2beta,5alpha)-Isomer; Cis-1 ,3-trans-1,4-(+-)-menthol; Cis-1,3-trans-1,4-(+-)-menthol; (+)-Neo-menthol; (+)-p-Menthan-3-ol; (+-)-(1R*,3R*,4S*)-Menthol; (+-)-Menthol; (+/-)-Menthol; (+/-)-p-Menthan-3-ol; (-)-(1R,3R,4S)-Menthol; (-)-Menthyl alcohol; (-)-menthol; (-)-p-Menthan-3-ol; (-)-trans-p-Menthan-cis-ol; (1R)-(-)-Menthol; (1R,2S,5R)-Menthol; (1R,3R,4S)-(-)-MENTHOL; (1S, 2S, 5R)-(+)-Neomenthol; (1S,2R,5R)-(+)-Isomenthol; (1S,2R,5S)-(+)-Menthol; (1S,2R,5S)-Menthol; (1r,2s,5r)-(-)-menthol; (L)-MENTHOL; (R)-(-)-Menthol; 2-Isopropyl-5-methylcyclohexanol; 3-p-Menthol; 4-Isopropyl-1-methylcyclohexan-3-ol; 5-Methyl-2-(1-methylethyl)-cyclohexanol; 5-Methyl-2-(1-methylethyl)cyclohexanol; 5-methyl-2-(propan-2-yl)cyclohexanol; 5-methyl-2-propan-2-ylcyclohexan-1-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antipruritics
|
||||
Structure |
Download2D MOL |
||||
Formula |
C10H20O
|
||||
InChI |
InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10-/m0/s1
|
||||
InChIKey |
NOOLISFMXDJSKH-AEJSXWLSSA-N
|
||||
CAS Number |
CAS 2216-51-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
10664240, 12055913, 15388629, 24853440, 46239658, 48420130, 57350830, 75929472, 83549269, 87572824, 91691148, 103067196, 103077027, 113456940, 117556867, 124765985, 124955140, 125332761, 128732142, 131305826, 132563800, 134972992, 135043092, 135650579, 136904077, 137255636, 143046433, 144208241, 152248194, 160687409, 162242944, 163772994, 170474419, 175269391, 179694062, 198960312, 223388335, 223702533, 225165383, 226834155, 249822667, 250139819
|
||||
ChEBI ID |
ChEBI:15409
|
||||
Target and Pathway | |||||
Target(s) | Transient receptor potential cation channel subfamily A member 1 | Target Info | Activator | [537080] | |
TRPM8 protein | Target Info | Activator | [537080] | ||
References | |||||
Ref 538582 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 022029. | ||||
Ref 539598 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2471). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.